{"name":"Timmune Biotech Inc.","slug":"timmune-biotech-inc","ticker":"","exchange":"","domain":"","description":"Timmune Biotech Inc. is a clinical-stage biotechnology company focused on developing innovative CAR-T therapies for the treatment of cancer. The company's pipeline includes several candidates in Phase 1 trials, targeting various hematological malignancies and solid tumors.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPR1c1dzBFdHM3NURvYVNoR3V3Z3AwSVpsOC0tMS12S1liUnpHU1FVMldxNmFYSnNWYmRIczNkQjVneTlJd3liUk1NTnFOUk9NNUJjTnRLVkYxZUZkZjN4QTdSQnpONkhLc3cxS3JXYy1Vdl91X1p1bnVhQm4tZlB0UTVNdm5Mckp6RWRhYUkxS2x3RklUSE9WZE9TMVl3bkx5TWJCczh1R2M3YTZtYUsw?oc=5","date":"2026-02-19","type":"trial","source":"Fierce Biotech","summary":"J&J halts enrollment in phase 2 trial of AC Immune-partnered Alzheimer's therapy - Fierce Biotech","headline":"J&J halts enrollment in phase 2 trial of AC Immune-partnered Alzheimer's therapy","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPN19hRGVGVW5NdUpWcWlkWElUZXZLM2ZDTkgzeVBObzltZGdFYWI4RzBqNWthOFBiQXdyREF1WlJFQ0IyUW42RVZhMmxHR1ltZU5CbUlnUUZkcklvQ3BmMnNmS09pQ0Q1QnV3eERaU0I0WlktWHJDcXBvd3p1bDJNajB0d1EtMFFFb25jbjNuVUJta1JidVZ2VFpWU1FRWGd4QWVR?oc=5","date":"2026-02-18","type":"patent","source":"Contract Pharma","summary":"Pluri Biotech Secures China Patent for Immune Cell Tech - Contract Pharma","headline":"Pluri Biotech Secures China Patent for Immune Cell Tech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgJBVV95cUxQdEc0VVZBelVtWi1NVkRxQ19mdFo5VTk5aUsyTmxENjhqQVV5YVhBekQyQlpZMmE3bVVsVTdReExnODZyblJPTjZLbW5CWm1henExSXZpNW9FX2VZZ1ZkOEJtbE9aZ0FwbktQVkIyVllOTXF3LW5TRGhQckl3ek1tSUNKcFFZMS1WZ201bWl2WElUa3NsbWd5TFdaX1RGQmNaRExaQWR3LW5TSXpsOXpZVkdLa3hITGU3U1hLSDVrX0ZnQXdscE9MVTE5b2IzaEpLY3lzTXhBbkUtY3o5aW53YXdOamNYbFpRZzI3aXF6b0VBMkNMR2F1bnVXWDFYekFZUURXcnh2WXhnLUZnM3RGOW5CbHZDQW54XzFHcjZLeVJfbEd2dTVwSzVoX3VOZC02bnctbk1KUXRtbGt5aWZoTllfUG9UR2VCYmxXcHNB?oc=5","date":"2026-02-10","type":"trial","source":"Business Wire","summary":"Enanta Pharmaceuticals to Present Preclinical Data for EDP-978, its KIT Inhibitor in Development for the Treatment of Type 2 Immune Diseases, at the 2026 AAAAI Annual Meeting - Business Wire","headline":"Enanta Pharmaceuticals to Present Preclinical Data for EDP-978, its KIT Inhibitor in Development for the Treatment of Ty","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPdDJ2QnNzTG90NjlwMkZxY0pmVENyQW9nTDQxR3pqUDBId201OEg1RDU5LVFvNVhqd1BNa1dZT2JYU0RZVUY0MG5kRDRseUpBS0tQRWk3V3VwOFprMnZ6eVIzb05MVG9Ga3g5YTgzM2JlMDZoOUplYnY1em5LWVdDbGFPdXNVSm5HZEg4NHd0RmRfbXpab1h5WXdOdWxpYWtyUW1aN2Rad0I?oc=5","date":"2026-02-03","type":"deal","source":"The Pharma Letter","summary":"WuXi licenses trispecific immune engager to Vertex - The Pharma Letter","headline":"WuXi licenses trispecific immune engager to Vertex","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQMDlsRFUzUm1sUVBjdkJCalR3TWdOVnZWV1MwcG5pMWlGelpHNjdRLWpoNUdnbFBMMGJvaC1jQzhVV2c1ZXYxWlFrQUFmcE82NXMxbnBSeElRNFViZVM4QXotVVU2ZWRLMmFzLXdYRHdSeXV1NmlRc0dCdGg3SG0zbVd6eU9tWWRFM3RjNVJtQnlIYkR4Mkp1elA0ODlDWm5VTlk1Ng?oc=5","date":"2026-02-02","type":"pipeline","source":"The Pharma Letter","summary":"Resolve M Therapeutics exits stealth with immune platform - The Pharma Letter","headline":"Resolve M Therapeutics exits stealth with immune platform","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQcHA1V0dJMTMybjBMRW1xOXlBNlJqdzMwQVY4RWdDZG5kR25fYXoxcHJwVmhCQ3BlVTE1TmM5WkdyV3luaGh4NFZxZ2NyWjI2dl8wNmwyclZwRWM0eGFYY1J4cFVKYkRneVB3T3V5MXlOSmRyekJnZjhBcEt6bndMYkxhYVpacVJnQzg2Qkx4THA4OUF6QWc4SlFFcWRBbE94SmlHUDJ1TkRrVzlFbDhYLTFiMmwzZElaUnRwS0pB?oc=5","date":"2026-01-29","type":"deal","source":"Fierce Biotech","summary":"Repertoire adds Lilly to range of Big Pharma partners in autoimmune deal worth up to $1.9B - Fierce Biotech","headline":"Repertoire adds Lilly to range of Big Pharma partners in autoimmune deal worth up to $1.9B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQSDBXZ243SnRELU9tTG5VZTBBaUFIQkVwVmJEYW42OGc5emVxOWVhSGlZcng5U1RDZE5IWUM5YUdYRE1VSDBpVFZxTW5iNUF0X29DSUlDa3RBaHpKRmhwODNuU1hlRmEyQzNDLU9VUlVYN29vb3dTZFl1T21FU2FWNXpGZklzS2hZQXNoV21KczXSAZYBQVVfeXFMTmdVSG5xdU5Qa2JKdFpoQWYyaHhkUkxfM1FUdmljWjc5Z2VZYkxxRzhsa0VmZWZXc2h1UWY4MFFibXlwbXplT0VBS2dITk5ya1oxVlRwN3JJUF9fOFkwQlZ5eHB1NmNwRWZQV0NvMVlmSDZka3laZlZTMjNaN1FXdWxiU0hUSC1XckpWb09qRGNVSDI3UXdR?oc=5","date":"2026-01-17","type":"pipeline","source":"BioInformant","summary":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide - BioInformant","headline":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQU1dqcmZ2ZkFWMGU2WVlXUmtKVUNHbUVDa05VYmJOaE51TW42MlJQS05uaHRMWHZ3MTU0Q1lMUklfY2pfemYzUGUzVWhCNGhkd08yc2FLMFNNUElxTWlkSlhZSVV3NG9EMll1VnBtTFRVLWFVTGxPT2tpckR4U0dJLS1WSXMxX05fbkg3ckIxOFBpR01VbGd0bFAySExQRVA5VlZiMnNlQUNzNmN5Um1RSFhVQ25Xam5N?oc=5","date":"2025-11-24","type":"deal","source":"BioPharma Dive","summary":"Biogen strikes deal with Versant-backed biotech to expand immune portfolio - BioPharma Dive","headline":"Biogen strikes deal with Versant-backed biotech to expand immune portfolio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNRWhnMWQ1bXFTNkp1Qk9BOUs3bHhSTmVucTV5d2NWaURJOGZNUFV2ZUI4ZFg3NFZfUlB5b1ZjX0UzOUVZMGo3Nmhvd2h3ZjVYVzF0TURhaTJBaVh1eG9PSUR0RjVDVDFJODJmUG5wSHNxaU15ZU1NZUM4bjgwanJNQ2lldTlPNm9yeGFmRnVyT1RlR2RWUFhWOVJLRkQ2cXhyRXNzaFhXSEktR3c?oc=5","date":"2025-11-13","type":"pipeline","source":"DVM360","summary":"Biotech company launches equine supplement targeting immune and cellular health - DVM360","headline":"Biotech company launches equine supplement targeting immune and cellular health - DVM360","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNSTZ4S2NGa0c5Tkh4WVVJMFUzUFVtdW5rU1BjcXQzVmxkWEN1RnpyOHZJT2V5R0txU0N5bmtFVS04UzItMkpkZXpSR1VuenVNS3JFLXlhZlZ3aER4SFdBeEVyYlVzNURSdkRRMlMybFllR1IxMERMX2VzWHdaNVRDX3pKRGN3eHlURnI5OVhiV1hkTEVXSDNUVVl1VVlQLVU?oc=5","date":"2025-11-04","type":"pipeline","source":"statnews.com","summary":"Jennifer Doudna spinoff aims to turn patients’ immune cells into CAR-T fighters with single shot - statnews.com","headline":"Jennifer Doudna spinoff aims to turn patients’ immune cells into CAR-T fighters with single shot","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPLTRoemFGeUh4b1RmYXV6WFFCWXhNMWNJQ3BxYXZ3RkJtejdQWjZ4elRUZ0RDaXBrNU5OZGQ2MjdqU25hbzlIMUJ0ZjlYbmNpZkJYcjJwYUFTa3c0cl8tX21VaFB6RVlZbThWcVNPUEZWVFpjTXFzU0JIUWhtc3dfdXdVdWNLelBGMDhMZURzV1lmZGNvZ2NBR0k3eHUzeVk?oc=5","date":"2025-10-08","type":"pipeline","source":"BioPharma Dive","summary":"Venture firms pour $101M into a biotech using the brain to fix the immune system - BioPharma Dive","headline":"Venture firms pour $101M into a biotech using the brain to fix the immune system","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxObWZWX3ZrSjN1Y0oyOEZhR3pCWldPNXRneWY3UFIzdE1wOGhMejVNR0s1M3BlaWY4dm9BSXNmY2lkT244OGU1Uk00LUw4YU9TTUI2REs0Y2ZjdU1SeDYxeWVCM05uWlZJck8xdndmbGYzbzNzZ1Nkb2ZaZEUtdXRURDhUVEwtX3Fic2lRa01QS09zN3BuTFJfamdGMGpBRHM4Qm1qQWR2SlVZRGZCZlZDNFlNRHhra3pHQ2xfSl9HTWNhQzA0RGlPbzJ6a0xGWTMzU1AySVc0Ujc?oc=5","date":"2025-06-12","type":"pipeline","source":"Business Wire","summary":"Parallel Bio Secures $21 Million in Series A to Advance Human-First Drug Discovery - Business Wire","headline":"Parallel Bio Secures $21 Million in Series A to Advance Human-First Drug Discovery","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}